Senseonics Holdings, Inc. (SENS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$7.82

From 52W high−22.49%

Volume417632.00

Market cap$423.79M

P/E (TTM)—

P/S (TTM)8.7x

Div yield—

Key dataOct 19, 2026

Open

$7.82

From 52W high

−22.49%

Volume

417632.00

Market cap

$423.79M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.4x

P/E (TTM)

—

RSI (14)

35.0

MomentumView details →

1D Return

+3.15%

YTD Return

+42.93%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−3.4x

EV/Sales

7.1x

P/S (TTM)

8.7x

P/B (TTM)

4.7x

ProfitabilityView details →

Gross Margin

54.87%

Net Margin

−225.34%

EBITDA Margin

−210.88%

ROE (TTM)

−121.12%

ROA (TTM)

−61.86%

Asset Turnover

0.35x

GrowthView details →

Revenue YoY

+90.63%

EPS YoY

−5.29%

FCF YoY

−76.71%

Revenue CAGR 3Y

+29.09%

EPS CAGR 3Y

+33.60%

EBITDA YoY

−71.71%

MomentumView details →

1D Return

+3.15%

YTD Return

+42.93%

1Y Return

−6.85%

RSI (14)

35.0

vs 50D SMA

−13.73%

vs 200D SMA

+10.69%

Capital & dividendView details →

Debt/Equity

0.68x

Current Ratio

6.74x

Quick Ratio

6.40x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.63

EPS Surprise

−2.84%

Beats (12Q)

2/12

Next Q EPS Est

−$0.46

Avg Surprise (4Q)

−9.18%

Rev Surprise

8.61%

Financials snapshotView financials →

Revenue (TTM)

48.55M

Net Income (TTM)

−109.39M

Op. CF (TTM)

−95.94M

Next earningsNov 4, 2026 →

Latest newsMore news →

Beta Bionics integrated Senseonics' Eversense 365 continuous glucose monitor into its iLet automated insulin delivery ecosystem.20d ago

Senseonics Holdings announced a strategic partnership with Beta Bionics to integrate the Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas, with a planned commercial launch in Q4 2026.36d ago

Similar companies

NeuroPace, Inc.NPCE Cryofocus Medtech (Shanghai) Co. Ltd.06922.HK AVITA Medical, Inc.RCEL Cerus CorporationCERS Sight Sciences, Inc.SGHT Orthofix Medical Inc.OFIX Find similar companies →

Latest newsMore news →

Beta Bionics integrated Senseonics' Eversense 365 continuous glucose monitor into its iLet automated insulin delivery ecosystem.20d ago Senseonics Holdings announced a strategic partnership with Beta Bionics to integrate the Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas, with a planned commercial launch in Q4 2026.36d ago Senseonics Holdings reported Q2 2026 revenue of $14.5 million, a 120% increase year-over-year, with a net loss of $36.7 million.75d ago